Phase II Study of Golidocitinib and Benmelstobart in Patients with R/R ENKTL (JACKPOT50)

Clinical trial NCT06733051 · RECRUITING

Trial details

NCT number: NCT06733051
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Natural Killer T-cell Lymphoma

Start date: 2024-01-27
Primary completion: 2026-12-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.